ERA-EDTA Registry Annual Report 2020
GHDx Entry last modified on: Oct 7, 2024
DALYs
Dataset Records for DALYs
Displaying 1 - 50 of 108
Niger Health Statistical Yearbook 2020
Annuaire Des Statistiques Sanitaires Niger, 2020
Report:
Epi surveillance - Subnationally representative
WHO Americas Region Bacterial Antimicrobial Resistance Burden Estimates 2019
GHDx Entry last modified on: Aug 14, 2023
WHO European Region Bacterial Antimicrobial Resistance Burden Estimates 2019
GHDx Entry last modified on: Oct 25, 2024
Global Bacterial Antimicrobial Resistance Burden Estimates 2019
GHDx Entry last modified on: May 23, 2024
Niger Health Statistical Yearbook 2019
Annuaire Des Statistiques Sanitaires Du Niger Annee 2019
Report:
Epi surveillance - Subnationally representative
ERA-EDTA Registry Annual Report 2019
GHDx Entry last modified on: Oct 7, 2024
Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa
GHDx Entry last modified on: Apr 10, 2023
The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study
GHDx Entry last modified on: Apr 10, 2023
The Economic Value of Long-Lasting Insecticidal Nets and Indoor Residual Spraying Implementation in Mozambique
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models
GHDx Entry last modified on: Apr 10, 2023
Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia
GHDx Entry last modified on: Apr 10, 2023
Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
GHDx Entry last modified on: Apr 10, 2023
Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar
GHDx Entry last modified on: Apr 10, 2023
Estimating the hypothetical dual health impact and cost-effectiveness of the Woman's Condom in selected sub-Saharan African countries
GHDx Entry last modified on: Apr 10, 2023
Costs and Consequences of Using Interferon- Release Assays for the Diagnosis of Active Tuberculosis in India
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania
GHDx Entry last modified on: Apr 10, 2023
Antenatal syphilis screening using point-of-care testing in low- and middle-income countries in Asia and Latin America: a cost-effectiveness analysis
GHDx Entry last modified on: Apr 10, 2023
Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis
GHDx Entry last modified on: Apr 10, 2023
Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation
GHDx Entry last modified on: Apr 10, 2023
The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study
GHDx Entry last modified on: Apr 10, 2023
Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda
GHDx Entry last modified on: Apr 10, 2023
Modeling the cost effectiveness of malaria control interventions in the highlands of western Kenya
GHDx Entry last modified on: Apr 10, 2023
Antenatal syphilis screening using point-of-care testing in Sub-Saharan African countries: a cost-effectiveness analysis
GHDx Entry last modified on: Apr 10, 2023
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
GHDx Entry last modified on: Apr 10, 2023
Cost-utility analysis of LED fluorescence microscopy in the diagnosis of pulmonary tuberculosis in Indian settings
GHDx Entry last modified on: Apr 10, 2023
The cost-effectiveness of HIV voluntary counseling and testing in China
GHDx Entry last modified on: Apr 10, 2023
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
GHDx Entry last modified on: Apr 10, 2023
Turkey Health Statistics Yearbook 2010
Türkіye Cumhurіyetі Sağlik Bakanliği Sağlik іstatіstіklerі Yilliği 2010
Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India
GHDx Entry last modified on: Apr 10, 2023
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis
GHDx Entry last modified on: Apr 10, 2023
Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience
GHDx Entry last modified on: Apr 10, 2023
Finding a needle in the haystack: the costs and cost-effectiveness of syphilis diagnosis and treatment during pregnancy to prevent congenital syphilis in Kalomo District of Zambia
GHDx Entry last modified on: Apr 10, 2023
Global Burden of Disease Study 2019 (GBD 2019) Risk Factors-Attributable Cancer Burden Estimates 2010–2019
GHDx Entry last modified on: Mar 3, 2023
Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda
GHDx Entry last modified on: Apr 10, 2023
Turkey Health Statistics Yearbook 2009
Türkіye Cumhurіyetі Sağlik Bakanliği Sağlik іstatіstіklerі Yilliği 2009
Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa
GHDx Entry last modified on: Apr 10, 2023
Vietnam Burden of Disease and Injury Study 2008
Report:
Verbal autopsy
The national burden of cerebrovascular diseases in Spain: a population-based study using disability-adjusted life years
GHDx Entry last modified on: Oct 21, 2020
Turkey Health Statistics Yearbook 2008
Türkіye Cumhurіyetі Sağlik Bakanliği Sağlik іstatіstіklerі Yilliği 2008
Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries
GHDx Entry last modified on: Apr 10, 2023
Estimating the Cost-Effectiveness of HIV Prevention Programmes in Vietnam, 2006-2010: A Modelling Study
GHDx Entry last modified on: Apr 10, 2023
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
GHDx Entry last modified on: Apr 10, 2023
Subscribe